Stryker Total Long Term Liabilities 2010-2024 | SYK
Stryker total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
- Stryker total long term liabilities for the quarter ending December 31, 2024 were $14.721B, a 9.87% increase year-over-year.
- Stryker total long term liabilities for 2024 were $14.721B, a 9.87% increase from 2023.
- Stryker total long term liabilities for 2023 were $13.398B, a 4.06% decline from 2022.
- Stryker total long term liabilities for 2022 were $13.965B, a 8.16% decline from 2021.
| Stryker Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $14,721 |
| 2023 | $13,398 |
| 2022 | $13,965 |
| 2021 | $15,205 |
| 2020 | $16,205 |
| 2019 | $12,960 |
| 2018 | $10,692 |
| 2017 | $8,732 |
| 2016 | $7,737 |
| 2015 | $4,210 |
| 2014 | $4,223 |
| 2013 | $4,039 |
| 2012 | $2,733 |
| 2011 | $2,623 |
| 2010 | $2,116 |
| 2009 | $1,035 |
| Stryker Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $14,721 |
| 2024-09-30 | $16,015 |
| 2024-06-30 | $12,442 |
| 2024-03-31 | $13,275 |
| 2023-12-31 | $13,398 |
| 2023-09-30 | $12,679 |
| 2023-06-30 | $13,464 |
| 2023-03-31 | $14,069 |
| 2022-12-31 | $13,965 |
| 2022-09-30 | $14,949 |
| 2022-06-30 | $15,954 |
| 2022-03-31 | $16,683 |
| 2021-12-31 | $15,205 |
| 2021-09-30 | $15,518 |
| 2021-06-30 | $15,626 |
| 2021-03-31 | $16,000 |
| 2020-12-31 | $16,205 |
| 2020-09-30 | $14,611 |
| 2020-06-30 | $14,324 |
| 2020-03-31 | $12,163 |
| 2019-12-31 | $12,960 |
| 2019-09-30 | $10,423 |
| 2019-06-30 | $10,465 |
| 2019-03-31 | $10,531 |
| 2018-12-31 | $10,692 |
| 2018-09-30 | $8,071 |
| 2018-06-30 | $8,064 |
| 2018-03-31 | $8,110 |
| 2017-12-31 | $8,732 |
| 2017-09-30 | $7,802 |
| 2017-06-30 | $7,705 |
| 2017-03-31 | $8,259 |
| 2016-12-31 | $7,737 |
| 2016-09-30 | $7,829 |
| 2016-06-30 | $7,817 |
| 2016-03-31 | $7,674 |
| 2015-12-31 | $4,210 |
| 2015-09-30 | $3,880 |
| 2015-06-30 | $4,591 |
| 2015-03-31 | $4,564 |
| 2014-12-31 | $4,223 |
| 2014-09-30 | $4,680 |
| 2014-06-30 | $4,514 |
| 2014-03-31 | $3,538 |
| 2013-12-31 | $4,039 |
| 2013-09-30 | $3,822 |
| 2013-06-30 | $3,808 |
| 2013-03-31 | $3,825 |
| 2012-12-31 | $2,733 |
| 2012-09-30 | $2,840 |
| 2012-06-30 | $2,821 |
| 2012-03-31 | $2,888 |
| 2011-12-31 | $2,623 |
| 2011-09-30 | $2,964 |
| 2011-06-30 | $2,215 |
| 2011-03-31 | $2,192 |
| 2010-12-31 | $2,116 |
| 2010-09-30 | $2,060 |
| 2010-06-30 | $2,020 |
| 2010-03-31 | $2,023 |
| 2009-12-31 | $1,035 |
| 2009-09-30 | $820 |
| 2009-06-30 | $791 |
| 2009-03-31 | $778 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $150.466B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.530B | 28.20 |
| Boston Scientific (BSX) | United States | $156.880B | 39.27 |
| EssilorLuxottica (ESLOY) | France | $133.537B | 0.00 |
| Medtronic (MDT) | Ireland | $110.863B | 16.19 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.634B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.687B | 27.69 |
| ResMed (RMD) | United States | $36.905B | 27.72 |
| GE HealthCare Technologies (GEHC) | United States | $33.485B | 15.90 |
| Agilent Technologies (A) | United States | $32.436B | 21.43 |
| Terumo (TRUMY) | Japan | $27.642B | 35.90 |
| Insulet (PODD) | United States | $22.854B | 89.71 |
| Koninklijke Philips (PHG) | Netherlands | $22.587B | 16.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.181B | 12.32 |
| Baxter (BAX) | United States | $16.247B | 12.13 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.648B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.231B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.767B | 23.55 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 14.18 |
| Prestige Consumer Healthcare (PBH) | United States | $4.402B | 19.67 |
| Perrigo (PRGO) | Ireland | $3.719B | 9.43 |
| Haemonetics (HAE) | United States | $3.532B | 15.39 |
| ICU Medical (ICUI) | United States | $3.480B | 25.66 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.097B | 25.73 |
| QuidelOrtho (QDEL) | United States | $2.263B | 15.56 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| LeMaitre Vascular (LMAT) | United States | $1.915B | 42.81 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.435B | 18.36 |
| Kestra Medical Technologies (KMTS) | United States | $1.264B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Green Thumb Industries (GTBIF) | United States | $1.182B | 26.59 |
| BioLife Solutions (BLFS) | United States | $1.121B | 0.00 |
| InMode (INMD) | Israel | $1.020B | 9.34 |
| Phibro Animal Health (PAHC) | United States | $0.973B | 12.44 |
| CeriBell (CBLL) | United States | $0.649B | 0.00 |
| Evolus (EOLS) | United States | $0.625B | 0.00 |
| Owens & Minor (OMI) | United States | $0.570B | 4.73 |
| Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.535B | 0.00 |
| Valneva SE (VALN) | France | $0.524B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.498B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.431B | 0.00 |
| Surmodics (SRDX) | United States | $0.409B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.335B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.94 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.321B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.288B | 51.30 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.276B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.53 |
| Cerus (CERS) | United States | $0.254B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.41 |
| Verano Holdings (VRNOF) | United States | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.224B | 6.31 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| Omeros (OMER) | United States | $0.187B | 0.00 |
| Brainsway (BWAY) | Israel | $0.187B | 49.55 |
| Quanterix (QTRX) | United States | $0.186B | 0.00 |
| Organigram Global (OGI) | Canada | $0.182B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.182B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.58 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Exagen (XGN) | United States | $0.128B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.77 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.080B | 10.32 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.061B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.35 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.86 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |